155 related articles for article (PubMed ID: 30914782)
1. B7H3 regulates differentiation and serves as a potential biomarker and theranostic target for human glioblastoma.
Zhang J; Wang J; Marzese DM; Wang X; Yang Z; Li C; Zhang H; Zhang J; Chen CC; Kelly DF; Hua W; Hoon DSB; Mao Y
Lab Invest; 2019 Jul; 99(8):1117-1129. PubMed ID: 30914782
[TBL] [Abstract][Full Text] [Related]
2. B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres.
Nehama D; Di Ianni N; Musio S; Du H; Patané M; Pollo B; Finocchiaro G; Park JJH; Dunn DE; Edwards DS; Damrauer JS; Hudson H; Floyd SR; Ferrone S; Savoldo B; Pellegatta S; Dotti G
EBioMedicine; 2019 Sep; 47():33-43. PubMed ID: 31466914
[TBL] [Abstract][Full Text] [Related]
3. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
4. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.
Lemke D; Pfenning PN; Sahm F; Klein AC; Kempf T; Warnken U; Schnölzer M; Tudoran R; Weller M; Platten M; Wick W
Clin Cancer Res; 2012 Jan; 18(1):105-17. PubMed ID: 22080438
[TBL] [Abstract][Full Text] [Related]
5. B7‑H3 promotes malignant progression of muscle‑invasive bladder cancer.
Xu ZL; Zhang Y; Wang L; Li F; Man HW; Li PF; Shan BE
Oncol Rep; 2018 Nov; 40(5):2722-2733. PubMed ID: 30132557
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.
Hasan T; Caragher SP; Shireman JM; Park CH; Atashi F; Baisiwala S; Lee G; Guo D; Wang JY; Dey M; Wu M; Lesniak MS; Horbinski CM; James CD; Ahmed AU
Cell Death Dis; 2019 Mar; 10(4):292. PubMed ID: 30926789
[TBL] [Abstract][Full Text] [Related]
7. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
[TBL] [Abstract][Full Text] [Related]
8. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
[TBL] [Abstract][Full Text] [Related]
9. MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma.
Jarboe JS; Anderson JC; Duarte CW; Mehta T; Nowsheen S; Hicks PH; Whitley AC; Rohrbach TD; McCubrey RO; Chiu S; Burleson TM; Bonner JA; Gillespie GY; Yang ES; Willey CD
Clin Cancer Res; 2012 Jun; 18(11):3030-41. PubMed ID: 22619307
[TBL] [Abstract][Full Text] [Related]
10. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
11. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
Marisetty AL; Lu L; Veo BL; Liu B; Coarfa C; Kamal MM; Kassem DH; Irshad K; Lu Y; Gumin J; Henry V; Paulucci-Holthauzen A; Rao G; Baladandayuthapani V; Lang FF; Fuller GN; Majumder S
Neuro Oncol; 2019 Jun; 21(6):775-785. PubMed ID: 30953587
[TBL] [Abstract][Full Text] [Related]
12. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
[TBL] [Abstract][Full Text] [Related]
13. Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo.
Kaur H; Phillips-Mason PJ; Burden-Gulley SM; Kerstetter-Fogle AE; Basilion JP; Sloan AE; Brady-Kalnay SM
Mol Cancer Res; 2012 Mar; 10(3):293-304. PubMed ID: 22267545
[TBL] [Abstract][Full Text] [Related]
14. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
15. The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.
Wu ZB; Cai L; Lin SJ; Lu JL; Yao Y; Zhou LF
Brain Res; 2013 Sep; 1529():16-25. PubMed ID: 23892108
[TBL] [Abstract][Full Text] [Related]
16. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
17. A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1.
Lee JS; Xiao J; Patel P; Schade J; Wang J; Deneen B; Erdreich-Epstein A; Song HR
Neuro Oncol; 2014 Jan; 16(2):191-203. PubMed ID: 24305710
[TBL] [Abstract][Full Text] [Related]
18. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
19. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J
Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]